96 related articles for article (PubMed ID: 1447748)
1. Diamine ligand release from the cisplatin analogue [meso-1,2-bis(2,6-dichloro-4- hydroxyphenyl)ethylenediamine]dichloroplatinum(II) in cell culture medium.
Bednarski PJ; Trümbach B; Kratochwil NA; Schönenberger H
J Med Chem; 1992 Nov; 35(23):4479-85. PubMed ID: 1447748
[TBL] [Abstract][Full Text] [Related]
2. Chemical stability, biological activity and cellular uptake of a cisplatin analogue having a 1,2-diarylethyleneamine ligand in cultures of human breast cancer cells.
Otto AM; Kratochwil NA; Eggers H; Bednarski PJ
J Cancer Res Clin Oncol; 1995; 121(1):31-8. PubMed ID: 7860616
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the conformational influences on the estrogenic activity of 1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines and of their platinum(II) complexes, II: Synthesis and studies on the estrogenic activity of cis- and trans[bis(2,6-dichloro-4-hydroxybenzylamine)]dihaloplatinum(II)-c omplexes.
Gust R; Schönenberger H
Arch Pharm (Weinheim); 1994 Dec; 327(12):763-9. PubMed ID: 7872853
[TBL] [Abstract][Full Text] [Related]
4. Ring-substituted diaqua(1,2-diphenylethylenediamine)platinum(II) sulfate reacts with DNA through a dissociable complex.
Bernges F; Holler E
Eur J Biochem; 1992 Sep; 208(3):573-9. PubMed ID: 1396663
[TBL] [Abstract][Full Text] [Related]
5. Displacement of the bidentate malonate ligand from (d,l-trans-1,2-diaminocyclohexane)malonatoplatinum(II) by physiologically important compounds in vitro.
Mauldin SK; Plescia M; Richard FA; Wyrick SD; Voyksner RD; Chaney SG
Biochem Pharmacol; 1988 Sep; 37(17):3321-33. PubMed ID: 3401260
[TBL] [Abstract][Full Text] [Related]
6. Analysis and quantitation of the DNA damage produced in cells by the cisplatin analog cis-[3H]dichloro(ethylenediamine)platinum (II).
Eastman A
Anal Biochem; 1991 Sep; 197(2):311-5. PubMed ID: 1785684
[TBL] [Abstract][Full Text] [Related]
7. NMR studies of models having the Pt(d(GpG)) 17-membered macrocyclic ring formed in DNA by platinum anticancer drugs: Pt complexes with bulky chiral diamine ligands.
Saad JS; Benedetti M; Natile G; Marzilli LG
Inorg Chem; 2011 May; 50(10):4559-71. PubMed ID: 21510625
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.
Dedon PC; Borch RF
Biochem Pharmacol; 1987 Jun; 36(12):1955-64. PubMed ID: 2954556
[TBL] [Abstract][Full Text] [Related]
9. Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing mice.
Schlemmer R; Spruss T; Bernhardt G; Schönenberger H
Arch Pharm (Weinheim); 2000 Dec; 333(12):397-403. PubMed ID: 11199469
[TBL] [Abstract][Full Text] [Related]
10. New synthetic route to [bis-1,2-(aminomethyl)benzene]dichloroplatinum(II) complexes, screening for cytotoxic activity in cisplatin-sensitive and resistant human cancer cell lines, and reaction with glutathione.
Rinke K; Grünert R; Bednarski PJ
Pharmazie; 2001 Oct; 56(10):763-9. PubMed ID: 11683118
[TBL] [Abstract][Full Text] [Related]
11. Effect of the amine non-leaving group on the structure and stability of DNA complexes with cis-[Pt(R-NH2)2(NO3)2].
Butour JL; Alvinerie P; Souchard JP; Colson P; Houssier C; Johnson NP
Eur J Biochem; 1991 Dec; 202(3):975-80. PubMed ID: 1765105
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua(1,2-diphenylethylenediamine) platinum(II) sulfates and specific platinum accumulation.
Reile H; Bernhardt G; Koch M; Schönenberger H; Hollstein M; Lux F
Cancer Chemother Pharmacol; 1992; 30(2):113-22. PubMed ID: 1600591
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
[TBL] [Abstract][Full Text] [Related]
14. Ring-substituted [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum (II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinoma.
Karl J; Gust R; Spruss T; Schneider MR; Schönenberger H; Engel J; Wrobel KH; Lux F; Haeberlin ST
J Med Chem; 1988 Jan; 31(1):72-83. PubMed ID: 3336035
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor evaluation of cis-(1,2-diaminoethane) dichloroplatinum (II) complexes linked to 5- and 6-methyleneuracil and -uridine analogues.
Kim JC; Lee MH; Choi SK
Arch Pharm Res; 1998 Aug; 21(4):465-9. PubMed ID: 9875477
[TBL] [Abstract][Full Text] [Related]
16. [1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. III. Detailed evaluation of the antitumor activity of the enantiomeric complexes on the human NIH:OVCAR-3 ovarian cancer cell line.
Bernhardt G; Gust R; Reile H; vom Orde HD; Müller R; Keller C; Spruss T; Schönenberger H; Burgemeister T; Mannschreck A
J Cancer Res Clin Oncol; 1992; 118(3):209-15. PubMed ID: 1548286
[TBL] [Abstract][Full Text] [Related]
17. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.
Plooy AC; Fichtinger-Schepman AM; Schutte HH; van Dijk M; Lohman PH
Carcinogenesis; 1985 Apr; 6(4):561-6. PubMed ID: 4039227
[TBL] [Abstract][Full Text] [Related]
18. The reaction of Pt-antitumor drugs with selected nucleophiles. II. Preparation and characterization of coordination compounds of Pt(II) and L-histidine.
Saudek V; Pivcová H; Nosková D; Drobnik J
J Inorg Biochem; 1985 Jan; 23(1):55-72. PubMed ID: 4038995
[TBL] [Abstract][Full Text] [Related]
19. Effect of thioethers on DNA platination by trans-platinum complexes.
Li C; Huang R; Ding Y; Sletten E; Arnesano F; Losacco M; Natile G; Liu Y
Inorg Chem; 2011 Sep; 50(17):8168-76. PubMed ID: 21812429
[TBL] [Abstract][Full Text] [Related]
20. Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graft; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplat inum (II) inhibits this process.
Schlemmer R; Spruss T; Bernhardt G; Schönenberger H
Arch Pharm (Weinheim); 2000 Mar; 333(2-3):69-71. PubMed ID: 10783521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
